Elixinol Wellness Ltd · ASX:EXL

Elixinol Wellness — Shareholder Meeting (July 2020)

15 slides from Elixinol Wellness's shareholder meeting presentation, Jul 30, 2020

  1. Slide 1: Annual General Meeting

    ANNUAL GENERAL MEETING 30 July 2020 For personal use only ELIXINOL 1

  2. Slide 2: Disclaimer

    DISCLAIMER For personal use only This presentation contains To the maximum extent permitted by law, no This presentation contains Such forward‐looking statements are based on summary information responsibility for any loss arising in any way from certain forward‐looking statements with numerous abou

  3. Slide 3: CEO's Presentation

    For personal use only CEO’S PRESENTATION Calm Before, During & After the Storm. Kind of Amazing 3 3

  4. Slide 4: Our Vision and Mission

    CEO's Presentation OUR VISION: For personal use only Building a global, consumer led and Elixinol-branded CBD nutraceuticals business. OUR MISSION Making a positive contribution to people’s health & wellness and the planet through the power of hemp products. Kind of Amazing 4

  5. Slide 5: What we stand for: Must Wins Values

    CEO's Presentation What we stand for.... For personal use only MUST WINS VALUES Heritage Global Knowledge Quality & Transparency Compliance Focus Champions in Our global footprint Our products are We maintain a strict hemp for delivers highest quality science & evidence compliance focus in a 25 year

  6. Slide 6: Results Highlights

    CEO's Presentation RESULTS HIGHLIGHTS For personal use only Improving fundamentals to build a global CBD consumer brand New brand identity Extended global Leaner operating launched reach model All global markets Early success building Moving into H2 2020 implemented launch omni-channel EU / UK with

  7. Slide 7: Enhancing Our Model

    CEO's Presentation ENHANCING OUR MODEL For personal use only Thriving in a V.U.C.A Environment Improve Cash Flow Enhance Margins Simplify Revenue Growth Markets Global E-Commerce (Q2 vs Q1) Making it easier to do business with EU/UK: 39% growth Q2 FY’20 (vs Q1 FY'20) 28% of global sales in H1 FY'20

  8. Slide 8: Agile + Responsible COVID Response

    CEO's Presentation AGILE + RESPONSIBLE COVID RESPONSE For personal use only Making necessity a virtue Safeguarding business Channel Shift to E- Responsible capital Amplify CBD continuity commerce, TV management relevance shopping & pharmacy • People are our 1st priority • Increased support for e- •

  9. Slide 9: New Sports Campaign: The New Elixinol

    CEO's Presentation NEW SPORTS CAMPAIGN THE NEW ELIXINOL For personal use only Fresh and differentiated range CBD blended capsules, proven health benefits 99 Daily Balance Immune Booster Happy Belly Body Comfort Stress Less Good Night 9 9

  10. Slide 10: Skincare Launch

    CEO's Presentation SKINCARE LAUNCH For personal use only 21st Century skincare, powered by CBD 10 10 Vegan Cruelty Free Natural 10 10 10

  11. Slide 11: Market Outlook & Regulatory Environment

    CEO's Presentation Market Outlook & Regulatory Environment For personal use only Strong market opportunity across US and Europe Regulation differs across key markets US regulatory framework uncertain: US market1: • Highly competitive and under-regulated market. In • Brightfield Group says mid-term,

  12. Slide 12: Hemp Foods Australia

    CEO's Presentation HEMP FOODS AUSTRALIA For personal use only Consistent growth with improved margins and leaner operations 12

  13. Slide 13: Global Growth

    CEO's Presentation GLOBAL GROWTH For personal use only Early global reach offers diversified opportunities ASIA • Most established and leading brand in Japan • Licensing agreement with Elixinol Japan. Supply of HFA products. AMERICAS • HFA testing route to market into China Cross • Est. 2014. One of

  14. Slide 14: Takeaways

    CEO's Presentation Takeaways For personal use only Elixinol Trusted & established Expanding positioned brand global presence within with fresh of Elixinol high growth nutraceuticals branded category offering products of global CBD Revenue growth from Skincare Virtually debt Elixinol branded opening

  15. Slide 15: For More Information

    For personal use only FOR MORE INFORMATION Investor relations and media please contact: Ron Dufficy Chief Financial Officer ron.dufficy@elixinolglobal.com

Elixinol Wellness — Shareholder Meeting (July 2020) on 6ix